VP, Global Clinical Supply,Pfizer, Inc.
Michael Ku is Vice President of Global Clinical Supply within the Medicinal Sciences organization of Pfizer’s Worldwide Research and Development. Dr. Ku has over 20 years of biopharmaceutical experience and currently provides strategic leadership for multiple global functions supporting Pfizer’s clinical trials. Dr. Ku is very committed with supporting the clinical development of new investigational products for patients as well as the advancement of technology and innovation.
Prior to joining Pfizer, Dr. Ku was the Global Head and Vice President of Clinical Pharmacy Research Services at Genzyme Corporation. He also held several roles of increasing responsibility at Astra Pharmaceuticals (currently AstraZeneca) and Novopharm Limited (currently Teva Canada Limited) in the areas of Clinical Research, Pharmacovigilance, Regulatory Affairs and Quality Assurance.
Dr. Ku has a Doctor of Pharmacy and Bachelor’s in Pharmacy from MCPHS University as well as a Master’s in Business Administration from Anna Maria College. He holds a Bachelor’s in Toxicology from the University of Toronto and is a graduate of the General Management Program from Harvard Business School. Dr. Ku has professional affiliations with the American Society of Health-System Pharmacists and the International Society of Pharmaceutical Engineers. He is also the Program Director for the Pfizer/MCPHS Biopharmaceutical Fellowship Program, as well as an Adjunct Assistant Professor of Pharmacy Practice at MCPHS University.